CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,482,591 | +259.8% | 99,436 | +164.2% | 0.00% | – |
| Q2 2023 | $412,049 | +284.0% | 37,630 | +9.1% | 0.00% | – |
| Q1 2022 | $107,311 | -19.3% | 34,505 | -12.0% | 0.00% | – |
| Q4 2021 | $133,000 | +64.2% | 39,219 | +76.1% | 0.00% | – |
| Q3 2021 | $81,000 | -56.5% | 22,272 | -47.9% | 0.00% | – |
| Q2 2021 | $186,000 | -1.6% | 42,743 | +2.4% | 0.00% | – |
| Q1 2021 | $189,000 | -20.3% | 41,734 | +1.2% | 0.00% | – |
| Q4 2020 | $237,000 | -19.1% | 41,254 | +2.0% | 0.00% | – |
| Q3 2020 | $293,000 | +96.6% | 40,426 | -3.6% | 0.00% | – |
| Q2 2020 | $149,000 | +115.9% | 41,925 | -9.8% | 0.00% | – |
| Q1 2020 | $69,000 | -14.8% | 46,461 | +12.9% | 0.00% | – |
| Q4 2019 | $81,000 | -63.2% | 41,169 | -3.0% | 0.00% | – |
| Q3 2019 | $220,000 | -27.6% | 42,430 | 0.0% | 0.00% | – |
| Q2 2019 | $304,000 | -39.2% | 42,430 | +12.5% | 0.00% | -100.0% |
| Q1 2019 | $500,000 | +73.0% | 37,701 | +2.7% | 0.00% | – |
| Q4 2018 | $289,000 | -31.0% | 36,716 | -3.1% | 0.00% | – |
| Q3 2018 | $419,000 | -26.6% | 37,883 | -11.0% | 0.00% | -100.0% |
| Q2 2018 | $571,000 | +57000.0% | 42,572 | +16465.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 257 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 257 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 257 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 257 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 257 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 257 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 257 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 257 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -50.0% | 257 | 0.0% | 0.00% | – |
| Q1 2015 | $2,000 | -33.3% | 257 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | – | 257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |